Safety, Tolerability and Performance of the NucleoCapture Extracorporeal Therapeutic Apheresis Device in the Reduction of Circulating cfDNA/NETs in Subjects With Pancreatitis
Clinical trial NCT06566638 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06566638
- Sponsor
- Liverpool University Hospitals NHS Foundation Trust
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-12-05
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.